"O Instituto das Pequenas Missionárias de Maria Imaculada (IPMMI), fundado por Madre Maria Teresa de Jesus Eucarístico, com sede em São José dos Campos/SP, é uma obra filantrópica com atuação nas áreas de saúde, educação e assistência social. Está presente em quatro estados brasileiros (São Paulo, Minas Gerais, Santa Catarina e Rio de Janeiro) e no Distrito Federal, além de prestar missões na Itália, Portugal e no continente africano. As religiosas do IPMMI administram vários hospitais e recantos para idosos (as), além de centros de educação infantil, casas de retiro, obras sociais, residências episcopais e atividades pastorais nas diversas Dioceses. O Instituto tem como missão a promoção da saúde por meio da excelência dos serviços presta"

During the past decade, Hospital Madre Teresa conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Madre Teresa" #1 sponsor was "United Therapeutics" with 3 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Madre Teresa" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Madre Teresa" are "Pulmonary Arterial Hypertension" (6 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Respiratory Failure" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Hospital Madre Teresa" in a lesser frequency.

Most popular intervention types in "Hospital Madre Teresa" are "Drug" (9 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Antiplatelet Monotherapy" (1 trials), "Brevibloc, 10 Mg/mL Intravenous Solution" (1 trials), "Empagliflozin" (1 trials) and "Femoral nerve block" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Madre Teresa" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Madre Teresa". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Madre Teresa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Madre Teresa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".